Hélène Dreau

1.8k total citations
26 papers, 495 citations indexed

About

Hélène Dreau is a scholar working on Genetics, Hematology and Cancer Research. According to data from OpenAlex, Hélène Dreau has authored 26 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 10 papers in Hematology and 9 papers in Cancer Research. Recurrent topics in Hélène Dreau's work include Chronic Lymphocytic Leukemia Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). Hélène Dreau is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). Hélène Dreau collaborates with scholars based in United Kingdom, Belgium and Sweden. Hélène Dreau's co-authors include Anna Schuh, Shirley Henderson, Jenny C. Taylor, Samantha J.L. Knight, Julie M. Old, Niko Popitsch, Pavlos Antoniou, Adele Timbs, Sarah Wordsworth and Alistair T. Pagnamenta and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hélène Dreau

24 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Dreau United Kingdom 11 239 153 146 125 103 26 495
Adele Timbs United Kingdom 10 313 1.3× 135 0.9× 179 1.2× 111 0.9× 174 1.7× 25 504
Koorosh Korfi United Kingdom 8 151 0.6× 228 1.5× 85 0.6× 81 0.6× 241 2.3× 18 549
Marian Stevens‐Kroef Netherlands 14 115 0.5× 366 2.4× 100 0.7× 133 1.1× 396 3.8× 30 692
Heather Bendall United States 8 161 0.7× 244 1.6× 184 1.3× 118 0.9× 126 1.2× 14 628
Hiro Tatetsu Japan 15 123 0.5× 356 2.3× 125 0.9× 52 0.4× 127 1.2× 35 600
Savvas Kinalis Denmark 11 81 0.3× 238 1.6× 63 0.4× 125 1.0× 155 1.5× 16 465
Shelly Gunn United States 12 148 0.6× 445 2.9× 119 0.8× 162 1.3× 45 0.4× 28 814
Olga Sala‐Torra United States 12 153 0.6× 233 1.5× 64 0.4× 66 0.5× 378 3.7× 31 707
JR Downing United States 10 93 0.4× 140 0.9× 143 1.0× 31 0.2× 188 1.8× 16 472
Nina Friesgaard Øbro Denmark 5 113 0.5× 249 1.6× 36 0.2× 156 1.2× 212 2.1× 12 469

Countries citing papers authored by Hélène Dreau

Since Specialization
Citations

This map shows the geographic impact of Hélène Dreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Dreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Dreau more than expected).

Fields of papers citing papers by Hélène Dreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Dreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Dreau. The network helps show where Hélène Dreau may publish in the future.

Co-authorship network of co-authors of Hélène Dreau

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Dreau. A scholar is included among the top collaborators of Hélène Dreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Dreau. Hélène Dreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vavoulis, Dimitris, Nishita Thota, J. Howard Brown, et al.. (2025). Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals. Nature Communications. 16(1). 430–430. 9 indexed citations
2.
Appleby, Niamh, et al.. (2023). Richter's transformation: Transforming the clinical landscape. Blood Reviews. 64. 101163–101163. 3 indexed citations
3.
4.
Roberts, Hannah, Maria Lopopolo, Alistair T. Pagnamenta, et al.. (2021). Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma. Scientific Reports. 11(1). 6408–6408. 12 indexed citations
5.
Rosenquist, Richard, Edwin Cuppen, Reinhard Buettner, et al.. (2021). Clinical utility of whole-genome sequencing in precision oncology. Seminars in Cancer Biology. 84. 32–39. 34 indexed citations
6.
Klintman, Jenny, Niamh Appleby, Basile Stamatopoulos, et al.. (2020). Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. Blood. 137(20). 2800–2816. 59 indexed citations
7.
Schwarze, Katharina, James Buchanan, Jilles M. Fermont, et al.. (2019). The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Genetics in Medicine. 22(1). 85–94. 140 indexed citations
8.
O’Sullivan, Jennifer, Jason Taylor, Aaron T. Gerds, et al.. (2019). Molecular Analysis in the Pacritinib Dose-Finding PAC203 Study in Patients with Myelofibrosis Refractory or Intolerant to Ruxolitinib. Blood. 134(Supplement_1). 4214–4214. 1 indexed citations
9.
Purshouse, Karin, Anna Schuh, Benjamin P. Fairfax, et al.. (2017). Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer. Molecular Case Studies. 3(3). a001362–a001362. 8 indexed citations
10.
Venn, Oliver, Alexander Dilthey, Avinash Gupta, et al.. (2017). Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA. npj Genomic Medicine. 2(1). 25–25. 8 indexed citations
11.
Stamatopoulos, Basile, et al.. (2016). PRESENCE OF MULTIPLE UNMUTATED IGHV REARRANGEMENTS IN CLL PATIENTS IS ASSOCIATED WITH A VERY SHORT TREATMENT- FREE SURVIVAL: RESULTS FROM 2 INDEPENDENT COHORTS. Haematologica. 101. 52–52. 5 indexed citations
12.
Stamatopoulos, Basile, Adele Timbs, Tom Smith, et al.. (2016). Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia. Leukemia. 31(4). 837–845. 37 indexed citations
13.
Stamatopoulos, Basile, Pavlos Antoniou, Dimitris Vavoulis, et al.. (2016). Characterization of Recurrent Mutations in Patient with a Richter Syndrome By Targeted Next Generation Sequencing. Blood. 128(22). 3200–3200. 2 indexed citations
14.
Hamblin, Angela, Adam Burns, Ruth Clifford, et al.. (2014). Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders. Blood. 124(21). 2373–2373. 1 indexed citations
15.
Knight, Samantha J.L., Christopher Yau, Ruth Clifford, et al.. (2012). Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia. 26(7). 1564–1575. 45 indexed citations
16.
Dreau, Hélène, et al.. (2011). Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica. 97(3). 340–343. 63 indexed citations
17.
Wagner, Sandrine Comparsi, Simone Martins de Castro, Tania González, et al.. (2010). Neonatal Screening for Hemoglobinopathies: Results of a Public Health System in South Brazil. Genetic Testing and Molecular Biomarkers. 14(4). 565–569. 13 indexed citations
18.
Dreau, Hélène, H Jackson, P Bignell, et al.. (2010). Characterization of a Novel Deletion Causing β-Thalassemia Major in an Afghan Family. Hemoglobin. 34(1). 110–114. 5 indexed citations
19.
Dreau, Hélène, et al.. (2010). Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing. Annals of Hematology. 89(12). 1215–1221. 11 indexed citations
20.
Dreau, Hélène, Janice McCarthy, Adele Timbs, et al.. (2009). Multiplex Ligation-Dependent Probe Amplification Identification of 17 Different β-Globin Gene Deletions (Including Four Novel Mutations) in the Uk Population. Hemoglobin. 33(6). 406–416. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adele Timbs Breakdown of academic impact, for papers by Koorosh Korfi Breakdown of academic impact, for papers by Marian Stevens‐Kroef Breakdown of academic impact, for papers by Heather Bendall Breakdown of academic impact, for papers by Hiro Tatetsu Breakdown of academic impact, for papers by Savvas Kinalis Breakdown of academic impact, for papers by Shelly Gunn Breakdown of academic impact, for papers by Olga Sala‐Torra Breakdown of academic impact, for papers by JR Downing Breakdown of academic impact, for papers by Nina Friesgaard Øbro
Rankless by CCL
2026